IRIS
ZANGRILLI, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.216
AS - Asia 976
EU - Europa 829
Continente sconosciuto - Info sul continente non disponibili 197
SA - Sud America 147
AF - Africa 19
OC - Oceania 9
Totale 8.393
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.152
SG - Singapore 396
CN - Cina 225
IT - Italia 174
RU - Federazione Russa 126
BR - Brasile 123
DE - Germania 92
IE - Irlanda 86
HK - Hong Kong 78
GB - Regno Unito 77
VN - Vietnam 77
SE - Svezia 74
FR - Francia 66
UA - Ucraina 53
BD - Bangladesh 52
CA - Canada 41
FI - Finlandia 31
IN - India 31
JP - Giappone 21
KR - Corea 17
UZ - Uzbekistan 15
PL - Polonia 12
MX - Messico 10
TR - Turchia 10
AU - Australia 9
KG - Kirghizistan 8
AR - Argentina 7
ES - Italia 7
ID - Indonesia 7
NL - Olanda 7
RO - Romania 7
CO - Colombia 6
IQ - Iraq 6
PK - Pakistan 6
MY - Malesia 5
BE - Belgio 4
EC - Ecuador 4
JO - Giordania 4
PH - Filippine 4
ZA - Sudafrica 4
AT - Austria 3
CL - Cile 3
DK - Danimarca 3
EG - Egitto 3
IL - Israele 3
MA - Marocco 3
NI - Nicaragua 3
CH - Svizzera 2
GT - Guatemala 2
KE - Kenya 2
LY - Libia 2
NG - Nigeria 2
NP - Nepal 2
SA - Arabia Saudita 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BS - Bahamas 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
LT - Lituania 1
MD - Moldavia 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
Totale 8.198
Salva come PNG Salva come JPEG
Città #
Wilmington 1.476
Houston 1.175
Woodbridge 1.101
Ashburn 268
Singapore 265
Fairfield 222
Chandler 196
San Jose 159
Ann Arbor 104
Seattle 90
Cambridge 85
Dublin 81
Beijing 80
Hong Kong 74
Council Bluffs 68
New York 68
Medford 61
Dearborn 45
Jacksonville 45
The Dalles 45
Los Angeles 39
Rome 33
Santa Clara 33
Lawrence 28
Ho Chi Minh City 26
Lauterbourg 23
Tokyo 21
Buffalo 19
Dallas 19
North Bergen 19
Brooklyn 18
Denver 18
Zhengzhou 18
Hanoi 17
Helsinki 17
Milan 17
Moscow 16
San Diego 16
Montreal 14
Chennai 12
Munich 12
Shanghai 12
São Paulo 12
Atlanta 11
Boardman 11
Brasília 10
Warsaw 10
Orem 9
Hefei 8
London 8
Manchester 8
Phoenix 8
Redondo Beach 8
Seoul 8
Bologna 7
Chicago 7
Menlo Park 7
Norwalk 7
Redmond 7
Redwood City 7
Stockholm 7
Toronto 7
Bari 6
Nuremberg 6
Sydney 6
Ankara 5
Belo Horizonte 5
Broken Arrow 5
Detroit 5
Esslingen am Neckar 5
Florence 5
Lappeenranta 5
Mexico City 5
Nanjing 5
Naples 5
Rio de Janeiro 5
San Francisco 5
Amman 4
Boston 4
Brussels 4
Charlotte 4
Da Nang 4
Kilburn 4
Palo Alto 4
Poplar 4
Raleigh 4
Sedico 4
Augusta 3
Baghdad 3
Cagliari 3
Carrboro 3
City of London 3
Cologne 3
Columbus 3
Genazzano 3
Guangzhou 3
Jinan 3
Managua 3
Mülheim 3
Nanchang 3
Totale 6.479
Salva come PNG Salva come JPEG
Nome #
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 510
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 497
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. 471
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 468
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 435
Erysipeloid cutaneous metastasis from bladder carcinoma 419
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 416
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 411
Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low Atherogenic Index. 397
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 371
Radiologically significant joint improvement in a patient affected by psoriatic arthritis treated with adalimumab 327
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice 294
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation 288
Paradoxical case effects of psoriasis following adalimumab therapy: A case series 280
One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast 253
Efficacy and safety of Adalimumab in difficult-to-treat psoriasis 223
Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation 217
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: preliminary results on metabolic biomarkers 213
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 197
Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigma 167
Omalizumab and adalimumab: a winning couple 163
Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study 160
A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: case report 158
Ixekizumab: One drug for an enigmatic psoriasis 152
Paradoxical psoriasis induced by anti-TNFα treatment: evaluation of disease-specific clinical and genetic markers 144
Clinical severity instruments 135
Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real‐world study 126
Risankizumab: How to choose the right dose in clinical practice? 124
Long-term efficacy of adalimumab in generalized pustular psoriasis 112
Effectiveness of ixekizumab in elderly patients for the treatment of moderate-to-severe psoriasis: results from a multicenter, retrospective real-life study in the Lazio region 96
Improvement of Psoriasis Using Oral Probiotic Streptococcus salivarius K-12: a Case–Control 24-Month Longitudinal Study 83
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: A 52-week Italian real-life experience 83
null 3
Totale 8.393
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022256 0 0 0 25 10 18 17 12 18 50 19 87
2022/2023439 35 51 23 53 36 95 37 22 45 13 15 14
2023/2024148 14 3 8 5 18 29 12 23 4 9 0 23
2024/2025624 27 119 92 27 6 36 66 28 50 62 69 42
2025/20261.442 126 50 146 145 134 57 227 158 107 137 72 83
2026/2027559 67 76 238 178 0 0 0 0 0 0 0 0
Totale 8.393